Next Article in Journal
Reactivity and Synthetic Applications of 4,5-Dicyanopyridazine: An Overview
Next Article in Special Issue
Effect of Sugars on Artemisinin Production in Artemisia annua L.: Transcription and Metabolite Measurements
Previous Article in Journal
HTS-Driven Discovery of New Chemotypes with West Nile Virus Inhibitory Activity
Previous Article in Special Issue
Biological Actions of Artemisinin: Insights from Medicinal Chemistry Studies
Article Menu

Export Article

Open AccessReview

The Molecular Mechanism of Action of Artemisinin—The Debate Continues

Department of Chemistry, University of Liverpool, Oxford Street, Liverpool L697ZD, UK
Liverpool School of Tropical Medicine, Pembroke Place Liverpool L35QA, UK
Author to whom correspondence should be addressed.
Molecules 2010, 15(3), 1705-1721;
Received: 14 January 2010 / Revised: 23 February 2010 / Accepted: 9 March 2010 / Published: 12 March 2010
PDF [417 KB, uploaded 18 June 2014]


Despite international efforts to ‘roll back malaria’ the 2008 World Malaria Report revealed the disease still affects approximately 3 billion people in 109 countries; 45 within the WHO African region. The latest report however does provide some ‘cautious optimism’; more than one third of malarious countries have documented greater than 50% reductions in malaria cases in 2008 compared to 2000. The goal of the Member States at the World Health Assembly and ‘Roll Back Malaria’ (RBM) partnership is to reduce the numbers of malaria cases and deaths recorded in 2000 by 50% or more by the end of 2010. Although malaria is preventable it is most prevalent in poorer countries where prevention is difficult and prophylaxis is generally not an option. The burden of disease has increased by the emergence of multi drug resistant (MDR) parasites which threatens the use of established and cost effective antimalarial agents. After a major change in treatment policies, artemisinins are now the frontline treatment to aid rapid clearance of parasitaemia and quick resolution of symptoms. Since artemisinin and its derivatives are eliminated rapidly, artemisinin combination therapies (ACT’s) are now recommended to delay resistance mechanisms. In spite of these precautionary measures reduced susceptibility of parasites to the artemisinin-based component of ACT’s has developed at the Thai-Cambodian border, a historical ‘hot spot’ for MDR parasite evolution and emergence. This development raises serious concerns for the future of the artemsinins and this is not helped by controversy related to the mode of action. Although a number of potential targets have been proposed the actual mechanism of action remains ambiguous. Interestingly, artemisinins have also shown potent and broad anticancer properties in cell lines and animal models and are becoming established as anti-schistosomal agents. In this review we will discuss the recent evidence explaining bioactivation and potential molecular targets in the chemotherapy of malaria and cancer. View Full-Text
Keywords: artemisinin; bioactivation; molecular targets; antimalarial; antitumor agent artemisinin; bioactivation; molecular targets; antimalarial; antitumor agent

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

O’Neill, P.M.; Barton, V.E.; Ward, S.A. The Molecular Mechanism of Action of Artemisinin—The Debate Continues. Molecules 2010, 15, 1705-1721.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top